Verisk Analytics, Inc (VRSK)
Key Takeaways:
Company Overview
Verisk Analytics, Inc. is a specialized data, analytics, and software provider focused almost entirely on the insurance ecosystem, with a primary emphasis on U.S. property and casualty insurers and an expanding international footprint. Its core offerings span underwriting data, forms and rules, loss-cost modeling, catastrophe and weather risk analytics, claims fraud detection, property estimating, casualty compliance, life insurance workflow automation, and specialty insurance software. The company’s value proposition is built on proprietary databases, long-tenured industry relationships, and deep regulatory expertise, with products embedded into customer workflows through recurring subscriptions and long-term agreements that represent the bulk of revenue. Verisk also benefits from a large installed base that includes the top U.S. P&C insurers. However, the business is tightly tied to insurance industry spending, regulation, catastrophe activity, data access rights, and the continued relevance of its models amid rapid advances in AI, cloud delivery, and insurer insourcing. Its profile is high-quality but not low-risk: durable recurring revenue, strong cash generation, and mission-critical products are offset by concentration risk, acquisition integration risk, leverage, and regulatory/cybersecurity exposure.
Business Segments
Economic Moat Analysis
Verisk merits a wide moat, but not an impenetrable one. Its core advantage comes from the combination of proprietary data, regulatory entrenchment, and workflow integration across the insurance value chain. These assets reinforce one another: more customers generate more data, more data improves analytics, better analytics increase stickiness, and regulatory roles make substitution harder. That said, the moat is not immune to erosion. Privacy regulation, AI-enabled competition, insurer insourcing, and shifts in data availability could gradually weaken some advantages. The moat is therefore strong and durable, but it depends on continued execution, data access, and credibility of the models rather than on monopoly-like control.
Verisk’s proprietary and contributory databases are massive, industry-specific, and continuously refreshed, creating a strong structural barrier to entry.
Its solutions are deeply embedded in underwriting, claims, compliance, and pricing workflows, making replacement costly, risky, and operationally disruptive.
Licensed statistical-agent and advisory roles in all 50 states plus other jurisdictions reinforce customer dependency and make the platform hard to replicate.
Long-standing credibility with insurers and regulators matters in a domain where accuracy, defensibility, and compliance are essential.
The cost to collect, validate, and maintain insurance data is spread across a large customer base, allowing strong operating leverage.
Products are not standalone tools; they sit inside mission-critical processes, increasing retention and making competitive displacement difficult.
Deep insurance and actuarial expertise improves model quality and product relevance, especially in regulated and technically complex workflows.
Key Strengths
- Recurring Revenue: A large majority of revenue comes from prepaid subscriptions and long-term contracts, which supports predictability and cash flow visibility.
- Customer Embedment: Products are integrated into underwriting, claims, compliance, and pricing workflows, making them difficult and costly to replace.
- Proprietary Data Scale: Verisk maintains extremely large, differentiated insurance databases that would be difficult for competitors to replicate economically.
- Industry Standard Position: Its forms, rules, and statistical-agent services are deeply embedded in U.S. P&C insurance operations and regulatory processes.
- Strong Client Base: The company serves most top U.S. P&C insurers, creating institutional trust and sticky enterprise relationships.
- Cash Generation: The business converts earnings into substantial operating cash flow, aided by prepaid billing and relatively limited working-capital strain.
- Platform Breadth: Verisk can cross-sell across underwriting, claims, catastrophe, specialty, and life solutions, increasing wallet share.
- Regulatory Knowledge: Its deep compliance and advisory expertise is a meaningful barrier to entry in a heavily regulated industry.
Identified Weaknesses
- Customer Concentration: A large share of revenue is tied to U.S. P&C insurers, leaving the company exposed to industry spending cycles.
- Leverage Build-Up: Debt increased materially, which reduces strategic flexibility and raises sensitivity to refinancing and interest-rate conditions.
- Acquisition Dependence: Growth has relied partly on acquisitions, increasing integration complexity and the risk of paying for synergies that never fully emerge.
- Margin Pressure: Higher SGA, IT spend, and amortization can limit operating leverage, especially when reinvestment and integration costs rise.
- Narrow End Market: The company remains heavily dependent on one vertical, limiting diversification and making demand more cyclical than the cash profile suggests.
- Data Dependency: Much of the core value depends on continued access to external customer, government, and third-party data sources.
- Model Risk: If analytics are wrong, outdated, or perceived as inferior, the reputation and relevance of the platform can be damaged.
- Capital Allocation Risk: Large share repurchases, acquisitions, and debt issuance can amplify returns but can also destroy value if timing is poor.
Growth Opportunities
- AI Enhancement: Applied AI and machine learning can improve workflow automation, claims handling, and underwriting precision if executed carefully and credibly.
- International Expansion: The company still has room to broaden penetration in the U.K., Europe, Canada, and select Asia-Pacific markets.
- Life Insurance Growth: FAST and SuranceBay extend Verisk into life and annuity workflows with modernization potential, though execution matters.
- Catastrophe Demand: Rising weather volatility, wildfire risk, flood risk, and reinsurance complexity should keep demand for catastrophe analytics relevant.
- Claims Automation: Generative AI, remote adjusting, and image analytics may improve productivity and deepen claims-product penetration.
- Specialty Insurance: The London and global specialty markets offer structurally attractive software and workflow opportunities with high switching costs.
- Cross-Sell Potential: Verisk can bundle data, software, and analytics across underwriting, claims, and compliance to increase customer lifetime value.
- Content Modernization: The Reimagine program could refresh legacy offerings and reduce churn if it truly improves speed, usability, and value.
Risk Factors
- Data Regulation: Privacy laws, FCRA-style rules, and evolving data-use restrictions could shrink usable data and limit product utility.
- Cyber Risk: A breach or data loss could damage trust, create liability, and deter both customers and data suppliers.
- AI Disintermediation: Customers or competitors may use AI and alternative data to replicate parts of Verisk’s value proposition at lower cost.
- Customer Insourcing: Larger insurers may build internal analytics capabilities and reduce reliance on outside vendors over time.
- Insurance Cyclicality: Weak premium growth, softer underwriting appetite, or deteriorating insurer profitability could slow spending on analytics.
- Regulatory Scrutiny: Insurance advisory and statistical services are subject to state oversight, antitrust sensitivity, and periodic examinations.
- Acquisition Integration: Missteps integrating acquired businesses could dilute margins and distract management.
- Cloud Concentration: Heavy reliance on a few cloud infrastructure providers creates operational and pricing lock-in risk.
- Climate Complexity: More severe and less predictable climate patterns may degrade model accuracy and increase liability exposure if outputs disappoint.
- Interest Rates: Higher-for-longer financing costs or refinancing risk could pressure earnings and capital deployment flexibility.
Valuation Metrics
Current multiples look growth-at-a-reasonable-price but not deep-value: P/E 25.79 (vs Forward P/E 19.32) implies the market expects earnings improvement. Forward P/E discount (~25.79/19.32=1.34x) supports a near-term estimate step-up.
PEG is 1.78: suggests growth is not “cheap,” but it’s in a fair-to-slightly-premium zone depending on the quality/consistency of growth.
Price-to-sales: P/S 6.97 is elevated for mature software-like businesses; however it can be justified if margins and ROIC remain strong.
Price-to-book: P/B is 1.93—moderate, not a distress multiple, consistent with an asset-light/IC-intensive model.
Cash-flow multiple: P/FCF 14.97 indicates investors are paying a meaningful premium for current cash generation.
Enterprise/value metrics: EV/EBITDA 39.56 is high, while EV/Sales 17.67 is also rich—both signal the market prices in sustained high-quality earnings and growth.
Overall valuation verdict: not a bargain on headline multiples, but forward P/E + PEG suggest fundamentals may still support the price if growth/margins hold.
Earnings & Profitability
Profitability is strong and quality appears high: ROA 7.71%, ROE 12.67%, and ROIC 10.87%—all consistent with durable economics.
Margin structure is healthy: Gross margin 44.81%, Oper. margin 28.24%, Profit margin 28.15% (near-operating levels imply limited below-the-line drag).
Earnings momentum: EPS (ttm) 6.51, with strong forward expectations: EPS next Y 8.69 and EPS next Q 1.93 (suggests estimate acceleration).
Year-over-year earnings growth: EPS Y/Y TTM is 12.67% and Sales Y/Y TTM is 10.87%, indicating solid mid-teens-ish earnings growth potential (given the provided EPS growth figure).
Quarterly trend: EPS Q/Q 7.71% and Sales Q/Q 12.67% (quarter-to-quarter uplift), supportive for a growth thesis.
Surprise/consistency signal: EPS/Sales Surprise is 2.61% (positive), suggesting recent results have not been consistently worse than expectations.
Earnings-risk note: without explicit recession sensitivity metrics, the main risk is valuation compression if growth or margins disappoint; margins look robust, which helps mitigate that risk.
Growth Analysis
Expected growth runway looks credible: EPS past 3/5Y growth is positive (EPS past 3/5Y shows 2.61% 8.51% in the CSV fields—still indicates historical improvement rather than stagnation).
Analyst trajectory: EPS next Y 8.69 vs EPS (ttm) 6.51 implies ~33.5% jump (8.69/6.51 - 1). That’s a material step-up and is a key driver of the forward multiple discount.
Sales growth: Sales Y/Y TTM 10.87% and Sales past 3/5Y 5.01% indicate revenue is growing steadily rather than exponentially—so the story is likely operating leverage and margin resilience.
Future EPS 5Y: EPS next 5Y is 7.16 (as provided) alongside EPS past 3/5Y figures—suggests continued but not hyper-growth; pairs well with a PEG near 1.78.
Bottom line: for a growth investor, the stock screens as mid-double-digit earnings growth with margin durability; for a value investor, it’s more of a “quality compounder” than a classic low-multiple turnaround.
Financial Health
Balance-sheet risk looks contained: Debt/Eq is 0.06 and LT Debt/Eq is 5.01% (low leverage, equity not overly strained by debt).
Liquidity is stable though not extremely high: Quick Ratio 1.01 and Current Ratio 1.01—adequate coverage, indicating the firm can meet short-term obligations without strain.
Cash generation capacity appears meaningful: Cash/sh is 1.01 (moderate per-share cash figure, consistent with an ongoing buy/reinvestment model).
Overall financial health verdict: low leverage + reasonable liquidity supports resilience through cycles and helps justify paying a quality premium.
Ownership Structure
Ownership is institution-heavy: Inst Own 89.06% (very strong institutional sponsorship), while Insider Own 2.36% indicates insiders are not dominating ownership decisions.
Insider transactions are modest (Insider Trans 0.28% in CSV): no strong insider sell/buy signal provided here.
Institutional participation supports liquidity and can reduce single-actor risk, but high institutional ownership can also mean crowded positioning and faster sentiment shifts.
Market Performance
Relative performance is mixed-to-weak: Perf YTD -11.54%, Perf Year -24.96%, and Perf 3Y -33.26% in the provided fields—suggesting the market has not rewarded the stock recently.
Short-term is also negative: Perf week -11.91%, Perf month -8.64%, Perf quarter -9.36% (near-term drawdown).
Despite the pullback, price remains near key technical levels (SMA20 167.85 vs Price 165.94): Price is near the 20-day moving average, hinting at potential stabilization but not a clear breakout.
52-week context: 52W high 237.29 and low 165.94 (current price sits at/near the 52W low), implying downside has likely already been partially repriced.
Market regime risk: given rich valuation metrics, any continued earnings disappointment could worsen multiple compression.
Momentum & Volatility
Volatility is moderate-high: Beta 1.15 and Volatility 1.50M (CSV shows a volatility measure; ATR (14) is 1.01). Beta >1 suggests the stock may move more than the market.
Momentum is weak: RSI (14) 44.81% (below 50, not oversold), and multiple negative performance windows indicate soft momentum rather than strong trend acceleration.
Short interest is low-to-moderate: Short Float 3.58% and Short Ratio 3.10; Short Interest 3.10% (interpreting CSV fields). This suggests limited “short squeeze” catalyst.
Relative volume 1.01 and last known volume 4.64M vs avg 4.64M (near normal), indicating no major exceptional volume-based breakout.
Investment Recommendations
value Investor:
With current price (~165.94) already near the 52W low, a value-style entry would target a discount to current fair expectations. Using valuation context (P/E 25.79, Forward P/E 19.32, PEG 1.78) and current near-bottom positioning, consider staged buys around 155–160, and a deeper “margin of safety” add closer to 145–150 if earnings estimates hold.
growth Investor:
For growth, prioritize the forward earnings runway. Since forward P/E is 19.32 and the stock is near the low end of its range, an attractive growth entry would be 155–165. If price mean-reverts from momentum weakness, initial entries near 160 with add-ons down to 150 are consistent with balancing growth and valuation risk.
Investment Summary
VRSK shows high-quality profitability (gross ~44.8%, op margin ~28%, ROIC ~10.9%) and credible growth (sales ~10.9% YoY; EPS next Y jumps to 8.69). Valuation is not cheap (P/E 25.8, PEG 1.78, EV/EBITDA 39.6), but forward P/E (19.3) improves the setup. With shares near the 52W low and weak recent performance, both value and growth cases favor staged entries around 155–165 (and possibly 145–150 for margin of safety).